Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trialÉric Deutsch, D. Azria, Anne Delarochefordiere et al.|Annals of Oncology|2013Cited by 89
Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: Long-term results of the UNICANCER ACCORD 16 phase II trialAntonin Lévy, Éric Deutsch, D. Azria et al.|Radiotherapy and Oncology|2015Cited by 38